118 related articles for article (PubMed ID: 14718790)
1. p33ING1b and estrogen receptor (ER) alpha.
Toyama T; Iwase H
Breast Cancer; 2004; 11(1):33-7. PubMed ID: 14718790
[TBL] [Abstract][Full Text] [Related]
2. p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domain.
Toyama T; Iwase H; Yamashita H; Hara Y; Sugiura H; Zhang Z; Fukai I; Miura Y; Riabowol K; Fujii Y
J Steroid Biochem Mol Biol; 2003 Oct; 87(1):57-63. PubMed ID: 14630091
[TBL] [Abstract][Full Text] [Related]
3. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).
Kuzmichev A; Zhang Y; Erdjument-Bromage H; Tempst P; Reinberg D
Mol Cell Biol; 2002 Feb; 22(3):835-48. PubMed ID: 11784859
[TBL] [Abstract][Full Text] [Related]
4. Human ING1 proteins differentially regulate histone acetylation.
Vieyra D; Loewith R; Scott M; Bonnefin P; Boisvert FM; Cheema P; Pastyryeva S; Meijer M; Johnston RN; Bazett-Jones DP; McMahon S; Cole MD; Young D; Riabowol K
J Biol Chem; 2002 Aug; 277(33):29832-9. PubMed ID: 12015309
[TBL] [Abstract][Full Text] [Related]
5. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
6. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
7. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
8. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.
Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR
Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor p33ING1b enhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells.
Zhu JJ; Li FB; Zhou JM; Liu ZC; Zhu XF; Liao WM
Cancer Biol Ther; 2005 Jan; 4(1):39-47. PubMed ID: 15662138
[TBL] [Abstract][Full Text] [Related]
10. Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions.
Nouman GS; Anderson JJ; Mathers ME; Leonard N; Crosier S; Lunec J; Angus B
Histopathology; 2002 Apr; 40(4):360-6. PubMed ID: 11943021
[TBL] [Abstract][Full Text] [Related]
11. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
[TBL] [Abstract][Full Text] [Related]
12. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.
Fritah A; Saucier C; Mester J; Redeuilh G; Sabbah M
Mol Cell Biol; 2005 Mar; 25(6):2419-30. PubMed ID: 15743834
[TBL] [Abstract][Full Text] [Related]
13. Function of the ING family of PHD proteins in cancer.
Gong W; Suzuki K; Russell M; Riabowol K
Int J Biochem Cell Biol; 2005 May; 37(5):1054-65. PubMed ID: 15743678
[TBL] [Abstract][Full Text] [Related]
14. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
15. Different HATS of the ING1 gene family.
Feng X; Hara Y; Riabowol K
Trends Cell Biol; 2002 Nov; 12(11):532-8. PubMed ID: 12446115
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
17. p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Cancer Res; 2002 Jan; 62(1):141-51. PubMed ID: 11782371
[TBL] [Abstract][Full Text] [Related]
18. Agonist-dependent repression mediated by mutant estrogen receptor alpha that lacks the activation function 2 core domain.
Jung DJ; Lee SK; Lee JW
J Biol Chem; 2001 Oct; 276(40):37280-3. PubMed ID: 11487586
[TBL] [Abstract][Full Text] [Related]
19. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
